|

Outcomes of Focal Ablation for Prostate Cancer

RECRUITINGSponsored by University of Texas Southwestern Medical Center
Actively Recruiting
SponsorUniversity of Texas Southwestern Medical Center
Started2023-02-01
Est. completion2026-08
Eligibility
Age18 Years – 90 Years
SexMALE
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT05478694

Summary

This study will be designed to define the efficacy and safety of ablative therapies in the management of localized prostate cancer and comprehensively evaluate quality of life outcomes and oncologic control following treatment.

Eligibility

Age: 18 Years – 90 YearsSex: MALEHealthy volunteers accepted
Inclusion Criteria:

* Men with histologically confirmed prostate adenocarcinoma diagnosed on prostate biopsy
* Men with histologically confirmed local recurrence of prostate cancer diagnosed on prostate biopsy and standard of care imaging excluding locoregional or metastatic disease
* Age 18-90 years.
* Life expectancy \> 1 year
* Ability to understand and the willingness to sign a written informed consent.

Exclusion Criteria:

* Anatomic abnormalities that do not allow for focal ablation
* Evidence of non-organ confined disease that is not feasible for ablation
* Has active urinary traction infection

Conditions2

CancerProstate Cancer

Locations1 site

UTSW
Dallas, Texas, 75390
Sonobia Garrett

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.